Viewing Study NCT06625593


Ignite Creation Date: 2025-12-25 @ 1:01 AM
Ignite Modification Date: 2025-12-25 @ 11:15 PM
Study NCT ID: NCT06625593
Status: RECRUITING
Last Update Posted: 2025-11-21
First Post: 2024-09-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors
Sponsor: BeOne Medicines
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module